Improvement of glycemic control after treatment with mosapride for diabetic gastropathy.
Koshiyama
H
H
Shimono
D
D
Wada
Y
Y
Nakamura
Y
Y
D000368:Aged; D001549:Benzamides / Q000627:therapeutic use*; D001786:Blood Glucose / Q000378:metabolism*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000188:drug therapy*; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D005767:Gastrointestinal Diseases / Q000150:complications / Q000188:drug therapy*; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D008297:Male; D009025:Morpholines / Q000627:therapeutic use*; D013272:Stomach Diseases / Q000150:complications / Q000188:drug therapy
D001549:Benzamides; D001786:Blood Glucose; D005765:Gastrointestinal Agents; D006442:Glycated Hemoglobin; D009025:Morpholines; C062720:mosapride